Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings

Written By :  Dr Johann Christopher
Written By :  Dr. Bipin Kumar Sethi
Published On 2024-10-30 04:30 GMT   |   Update On 2024-10-30 09:15 GMT

Bringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this episode, we have two distinguished experts Dr Johann Christopher, a Consultant Cardiologist at CARE Hospital, Hyderabad, and Dr Bipin Kumar Sethi, a renowned Endocrinologist at CARE Hospitals, Hyderabad.

With vast experience in their respective fields, Dr Christopher and Dr Sethi bring a comprehensive perspective on how they utilize dapagliflozin in their clinical practice.

Dapagliflozin is a popular choice among doctors for managing Type 2 Diabetes and also plays a crucial role in treating heart failure and chronic kidney disease (CKD).

In this episode, they share their insights on:

1) Cardio-renal-metabolic benefits of the use of dapagliflozin in T2DM patients as well as cardiology settings

2) Applicability of Dapagliflozin Sitagliptin dual combination in cardiology settings

3) After how many years do Indian T2DM patients fail to achieve glucose control with two agents & what are the considerations & need for triple agents in these patients?

4) Applicability of Dapagliflozin Sitagliptin Metformin triple combination in cardiology and Diabetes settings

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News